ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014